The future of drug delivery - targeted, timed and non-toxic release of APIs using MOFs

The future of drug delivery - targeted, timed and non-toxic release of APIs using MOFs

By | pharmaceuticals | No Comments

How a drug — more precisely an active pharmaceutical ingredient (API) — is taken up by the body and delivered to the site of disease, has a tremendous effect on the efficacy of the.

How toxic are MOFs?

How toxic are MOFs?

By | pharmaceuticals | No Comments

The current developments around the application of metal-organic frameworks (MOFs) for pharmaceutical and biomedical applications are forcing us to have a closer look at how harmful.

Improving pharmaceutical and biomedical applications through metal-organic frameworks (MOFs)

Improving pharmaceutical and biomedical applications through metal-organic frameworks (MOFs)

By | pharmaceuticals | No Comments

Starting with the first publication about metal-organic frameworks (MOFs) in 1999, MOFs have seen a rapid growth in the last years and have proven to be of great interest to the.